ZA201204248B - Drug combination with theobromine and its use in therapy - Google Patents

Drug combination with theobromine and its use in therapy

Info

Publication number: ZA201204248B
Authority: ZA; South Africa
Prior art keywords: theobromine; therapy; drug combination; drug; combination
Prior art date: 2009-11-13

Application number

ZA2012/04248A

Inventor

John Brew

Robin Mark Bannister

Original Assignee

Biocopea Lilmited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-11-13

Filing date

2012-06-11

Publication date

2013-02-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41509324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201204248(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-06-11 Application filed by Biocopea Lilmited filed Critical Biocopea Lilmited

2013-02-27 Publication of ZA201204248B publication Critical patent/ZA201204248B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA2012/04248A 2009-11-13 2012-06-11 Drug combination with theobromine and its use in therapy ZA201204248B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0919889.6A GB0919889D0 (en)	2009-11-13	2009-11-13	Drug composition and its use in therapy
PCT/GB2010/051895 WO2011058373A2 (en)	2009-11-13	2010-11-12	Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number	Publication Date
ZA201204248B true ZA201204248B (en)	2013-02-27

Family

ID=41509324

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA2012/04248A ZA201204248B (en)	2009-11-13	2012-06-11	Drug combination with theobromine and its use in therapy

Country Status (17)

Country	Link
EP (1)	EP2498777A2 (en)
JP (2)	JP2013510841A (en)
CN (1)	CN102753174A (en)
AU (1)	AU2010317667B2 (en)
BR (1)	BR112012011227A2 (en)
CA (1)	CA2780703A1 (en)
CO (1)	CO6551744A2 (en)
GB (1)	GB0919889D0 (en)
IL (1)	IL219768A0 (en)
MX (1)	MX2012005532A (en)
NZ (1)	NZ599949A (en)
PE (1)	PE20130147A1 (en)
PH (1)	PH12012501369A1 (en)
RU (1)	RU2519086C2 (en)
UA (1)	UA108993C2 (en)
WO (1)	WO2011058373A2 (en)
ZA (1)	ZA201204248B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9314465B2 (en)	2009-06-16	2016-04-19	Infirst Healthcare Limited	Drug combinations and uses in treating a coughing condition
US9308211B2 (en)	2009-06-16	2016-04-12	Infirst Healthcare Limited	Drug combinations and uses in treating a coughing condition
GB0910375D0 (en)	2009-06-16	2009-07-29	Biocopea Ltd	Drug composition and its use in therapy
GB201111485D0 (en) *	2011-07-05	2011-08-17	Biocopea Ltd	Drug composition and its use in therapy
US10016437B2 (en)	2009-06-16	2018-07-10	Infirst Healthcare Limited	Drug combinations and uses in treating a coughing condition
WO2017117347A1 (en) *	2015-12-30	2017-07-06	Markovitz M D Paul	Method of treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5834479A (en) *	1993-03-05	1998-11-10	Mayer; David J.	Method and composition for alleviating pain
SK69799A3 (en) *	1996-11-25	2000-06-12	Procter & Gamble	Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
HUP9700654A2 (en) *	1997-03-26	1999-09-28	Dezső Korbonits	Antitussive compositions containing theobromine
US20030206942A1 (en) *	1998-09-25	2003-11-06	Neema Kulkarni	Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6207674B1 (en) *	1999-12-22	2001-03-27	Richard A. Smith	Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
ES2303640T3 (en) *	2003-05-29	2008-08-16	Unilever N.V.	COMPOSITION FOR HAIR TREATMENT.
US20060153926A1 (en) *	2005-01-10	2006-07-13	Bascom Charles C	Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) *	2006-06-26	2008-01-03	Levine Brian M	Combination cough treatment compounds and method of treating common coughs
US20080176955A1 (en) *	2007-01-16	2008-07-24	Victory Pharma, Inc.	Combined administration of benzonatate and guaifenesin

2009
- 2009-11-13 GB GBGB0919889.6A patent/GB0919889D0/en not_active Ceased
2010
- 2010-11-12 MX MX2012005532A patent/MX2012005532A/en active IP Right Grant
- 2010-11-12 CN CN2010800516299A patent/CN102753174A/en active Pending
- 2010-11-12 EP EP10825831A patent/EP2498777A2/en not_active Ceased
- 2010-11-12 JP JP2012538415A patent/JP2013510841A/en active Pending
- 2010-11-12 PH PH1/2012/501369A patent/PH12012501369A1/en unknown
- 2010-11-12 WO PCT/GB2010/051895 patent/WO2011058373A2/en active Application Filing
- 2010-11-12 CA CA2780703A patent/CA2780703A1/en not_active Abandoned
- 2010-11-12 NZ NZ599949A patent/NZ599949A/en not_active IP Right Cessation
- 2010-11-12 AU AU2010317667A patent/AU2010317667B2/en not_active Ceased
- 2010-11-12 PE PE2012000649A patent/PE20130147A1/en not_active Application Discontinuation
- 2010-11-12 RU RU2012124038/15A patent/RU2519086C2/en not_active IP Right Cessation
- 2010-11-12 BR BR112012011227A patent/BR112012011227A2/en not_active IP Right Cessation
- 2010-12-11 UA UAA201207164A patent/UA108993C2/en unknown
2012
- 2012-05-11 CO CO12078027A patent/CO6551744A2/en not_active Application Discontinuation
- 2012-05-13 IL IL219768A patent/IL219768A0/en unknown
- 2012-06-11 ZA ZA2012/04248A patent/ZA201204248B/en unknown
2016
- 2016-01-07 JP JP2016001487A patent/JP6118919B2/en active Active

Also Published As

Publication number	Publication date
JP6118919B2 (en)	2017-04-19
GB0919889D0 (en)	2009-12-30
MX2012005532A (en)	2012-09-28
PH12012501369A1 (en)	2012-10-22
NZ599949A (en)	2013-08-30
EP2498777A2 (en)	2012-09-19
WO2011058373A3 (en)	2011-07-07
JP2016128439A (en)	2016-07-14
PE20130147A1 (en)	2013-03-13
AU2010317667B2 (en)	2014-05-29
CN102753174A (en)	2012-10-24
JP2013510841A (en)	2013-03-28
UA108993C2 (en)	2015-07-10
RU2519086C2 (en)	2014-06-10
BR112012011227A2 (en)	2017-06-13
WO2011058373A2 (en)	2011-05-19
IL219768A0 (en)	2012-07-31
RU2012124038A (en)	2013-12-20
AU2010317667A1 (en)	2012-06-07
CA2780703A1 (en)	2011-05-19
CO6551744A2 (en)	2012-10-31

Publication	Publication Date	Title
IL222006A (en)	2016-04-21	Conjugates of pyrrolobenzodiazepines and their use in therapy
IL211952A (en)	2015-11-30	Implantable device for the delivery of risperidone and methods of use thereof
PL2987803T3 (en)	2019-04-30	Sap variants and their use
IL214244A0 (en)	2011-09-27	Scriptaid isosteres and their use in therapy
GB0921803D0 (en)	2010-01-27	Drug composition and its use in therapy
ZA201204248B (en)	2013-02-27	Drug combination with theobromine and its use in therapy
IL224953A (en)	2016-03-31	Theobromine in combination with an expectorant or a mucolytic for use in therapy
ZA201204247B (en)	2013-02-27	Drug combination with theobromine and its use in therapy
GB201211237D0 (en)	2012-08-08	CDK5 inhibitors and therapeutic uses thereof
GB2460181B (en)	2010-08-18	Depsipeptides and their therapeutic use
GB2460178B (en)	2010-08-18	Depsipeptides and their therapeutic use
GB0917533D0 (en)	2009-11-25	Azaphthalocyanines and their use in printing
GB0921805D0 (en)	2010-01-27	Drug composition and its use in therapy
GB0910375D0 (en)	2009-07-29	Drug composition and its use in therapy
GB0905970D0 (en)	2009-05-20	Depsipeptides and their therapeutic use
GB2460180B (en)	2011-08-17	Depsipeptides and their therapeutic use
GB0818663D0 (en)	2008-11-19	Gene regulation and its use in therapy
GB0920267D0 (en)	2010-01-06	Drug combination and its use in therapy
GB0909354D0 (en)	2009-07-15	Drug composition and its use in therapy
GB0909352D0 (en)	2009-07-15	Drug composition and its use in therapy
GB0919890D0 (en)	2009-12-30	Drug composition and its use in therapy
GB0918728D0 (en)	2009-12-09	Drug composition and its use in therapy
GB0921804D0 (en)	2010-01-27	Drug composition and its use in therapy
GB0918727D0 (en)	2009-12-09	Drug composition and its use in therapy
EP2234667A4 (en)	2011-06-01	Therapy calculation and therapy delivery modes